GEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Synageva BioPharma Corp's other current liabilities for the quarter that ended in Mar. 2015 was $0.97 Mil.
Synageva BioPharma Corp's quarterly other current liabilities increased from Sep. 2014 ($0.66 Mil) to Dec. 2014 ($0.91 Mil) and increased from Dec. 2014 ($0.91 Mil) to Mar. 2015 ($0.97 Mil).
Synageva BioPharma Corp's annual other current liabilities increased from Dec. 2012 ($0.00 Mil) to Dec. 2013 ($0.14 Mil) and increased from Dec. 2013 ($0.14 Mil) to Dec. 2014 ($0.91 Mil).
The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.
Synageva BioPharma Corp Annual Data
|Other Current Liab.||0.00||0.00||-0.00||0.00||0.00||0.00||0.45||0.00||0.14||0.91|
Synageva BioPharma Corp Quarterly Data
|Other Current Liab.||0.00||-0.00||0.00||0.00||0.14||0.65||0.64||0.66||0.91||0.97|